Q4 2025 earnings call: ibezapolstat rCDI trial plan, FDA one-trial shift, cash update, and Phase II data—read now.

New infrastructure strengthens Africa-based clinical trial logistics, reducing costs and accelerating timelines for ...

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that ...

The Patient Advocate Foundation and the PAN Foundation have announced a strategic merger to create the nation’s most ...

Polyrizon Ltd. (Nasdaq: PLRZ) ('Polyrizon” or the 'Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the successful production of a ...

FIRST SITE INITIATION VISIT COMPLETED IN AUSTRALIA SARASOTA, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-tar ...

“Our partnership with CRIO accelerates our strategy connecting site-level eSource and the Medidata Platform,” said Tom Doyle, chief technology officer, Medidata. “This will accelerate workflows for ...

A prospective feasibility study in an urgent care clinic tested a conversational AI system (AMIE) with 100 real patients to evaluate whether it could safely collect medical histories before doctor ...

Sport-related concussions are mild traumatic brain injuries that demand timely recognition and management. This review explores current evidence on pathophysiology, diagnosis, and treatment strategies ...

During MS Awareness Month, a Groundbreaking Research-and-Care Model Looks Back on 20 Years of Firsts I am eager to see ...

All required regulatory approvals secured for trial site onboarding and patient enrollment at three Australian sitesPotential first and only pharmacological treatment for the most prominent neurologic ...

In a partnership between the UCSF School of Nursing and UCSF Health, nursing experts are mentoring UCSF Health bedside nurses ...